Regeneron Pharmaceuticals shares owned by Syntax Advisors
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Syntax Advisors
from 13F filings
Historical chart of Syntax Advisors investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Syntax Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Regeneron Pharmaceuticals by Syntax Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $232k | 282 | 822.96 |
2023-06-30 | $221k | 307 | 718.54 |
2023-03-31 | $263k | 320 | 821.67 |
2022-12-31 | $231k | 320 | 721.49 |
2022-09-30 | $247k | 359 | 688.02 |
2022-06-30 | $251k | 425 | 590.59 |
2022-03-31 | $251k | 359 | 699.16 |
2021-12-31 | $246k | 390 | 630.77 |